• Home >
  • 2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective

2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective

 

01-Nov-2010  /  Research Code: N836-01-00-00-00  /  SKU: HC02169-NA-CR_07778  /  
Region: North America

Regular Price: USD 10,000.00

Special Price USD 7,000.00

30% OFF

* Required Fields

Regular Price: USD 10,000.00

Special Price USD 7,000.00

PAY BY INVOICE

Be the first to review this product

This study encompasses feedback provided by U.S. physicians who treat inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug. The corresponding patient deliverable is titled: "2008 U.S. Inflammatory Diseases Drug Delivery: Patient Perspective" (N835).

Table of Contents

2008 U.S. Inflammatory Diseases Drug Delivery, 2008 U.S. Inflammatory Diseases Drug DeliveryPhysician PerspectiveResearch Service




Related Research

PCHA and Partners HealthCare Connected Health Conference, 2018

Release Date : 21-Nov-18

Region : North America

Innovations in Medical Device Cybersecurity Solutions, ECG Monitoring, Artificial Chordae Delivery Systems, Implantable Pulse Generators, Mobile Health Platforms, Teleconsultation Services, and Laser Endomicroscopy

Release Date : 16-Nov-18

Region : Global

Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine

Release Date : 13-Nov-18

Region : Global

Artificial Intelligence Revolutionizing the Pharmaceutical Industry

Release Date : 13-Nov-18

Region : Global

Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

Release Date : 09-Nov-18

Region : Global

Innovations in Defibrillators, Disinfection Systems, Orthopedic Implant Designing System, Alzheimer’s Detection, Breast Cancer Diagnosis, and Drug-eluting Stents

Release Date : 19-Oct-18

Region : Global

Unveiling the Potential of Novel Life Sciences Platforms in Stem Cells, Microbiome, Computational Genomics, and Advanced Diagnostics

Release Date : 12-Oct-18

Region : Global

Technology Growth Series--Market Trends and Emerging Opportunities for Visualization

Release Date : 29-Sep-18

Region : Global

Digital Innovations Creating an Immersive Environment for Health Monitoring

Release Date : 28-Sep-18

Region : Global

Innovations in AR-based Surgical Imaging, Mobile X-ray, Rapid Diagnostic Tests, and Image-guided Radiation Therapy

Release Date : 28-Sep-18

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.